[1]
H. Mushtaq, R. Kouser, and A. Hassan, “Association of Gut Microbiota Derived Metabolites (TMAO and SCFAs) with Insulin Resistance Among Patients with Metabolic Syndrome: Gut Microbiota Metabolites and Insulin Resistance in Metabolic Syndrome”, Dev. med. life sci., vol. 3, no. 3, pp. 3–7, Mar. 2026, doi: 10.69750/dmls.03.03.0198.